• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Mezawa Yoshihiro  目澤 義弘

ORCIDConnect your ORCID iD *help
Researcher Number 50966538
Other IDs
Affiliation (Current) 2025: 順天堂大学, 医学部, 助教
Affiliation (based on the past Project Information) *help 2025: 順天堂大学, 医学部, 助教
2023: 順天堂大学, 医学部, 助教
2022: 順天堂大学, 医学部, 助手
Review Section/Research Field
Principal Investigator
Basic Section 50010:Tumor biology-related / 0901:Oncology and related fields
Keywords
Principal Investigator
癌関連線維芽細胞 / 癌微小環境 / 分子サブタイプ / 大腸癌 / エピゲノム解析 / 転写因子 / 乳癌
  • Research Projects

    (3 results)
  • Research Products

    (3 results)
  • Co-Researchers

    (1 People)
  •  骨発生転写因子による乳癌関連線維芽細胞myCAFの癌促進能制御メカニズムの解明Principal Investigator

    • Principal Investigator
      目澤 義弘
    • Project Period (FY)
      2025 – 2026
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 50010:Tumor biology-related
    • Research Institution
      Juntendo University
  •  大腸癌分子サブタイプが規定する癌間質相互作用の分子メカニズム解明Principal Investigator

    • Principal Investigator
      目澤 義弘
    • Project Period (FY)
      2023 – 2024
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 50010:Tumor biology-related
    • Research Institution
      Juntendo University
  •  Exploration of transcription factors that induce tumor-promoting subsets of breast carcinoma-associated fibroblastsPrincipal Investigator

    • Principal Investigator
      Mezawa Yoshihiro
    • Project Period (FY)
      2022 – 2023
    • Research Category
      Grant-in-Aid for Research Activity Start-up
    • Review Section
      0901:Oncology and related fields
    • Research Institution
      Juntendo University

All 2023

All Journal Article Presentation

  • [Journal Article] Glutamine deficiency drives transforming growth factor‐β signaling activation that gives rise to myofibroblastic carcinoma‐associated fibroblasts2023

    • Author(s)
      Mezawa Yoshihiro、Wang Tingwei、Daigo Yataro、Takano Atsushi、Miyagi Yohei、Yokose Tomoyuki、Yamashita Toshinari、Yang Liying、Maruyama Reo、Seimiya Hiroyuki、Orimo Akira
    • Journal Title

      Cancer Science

      Volume: 114 Issue: 11 Pages: 4376-4387

    • DOI

      10.1111/cas.15955

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-23K14603, KAKENHI-PROJECT-22K19469, KAKENHI-PROJECT-22K20837, KAKENHI-PROJECT-22H04922, KAKENHI-PROJECT-22H04923, KAKENHI-PROJECT-23K24192, KAKENHI-PROJECT-23K27506
  • [Journal Article] Increased <scp>RUNX3</scp> expression mediates tumor‐promoting ability of human breast cancer‐associated fibroblasts2023

    • Author(s)
      Koyama Yu、Okazaki Hiroya、Shi Yang、Mezawa Yoshihiro、Wang Zixu、Sakimoto Mizuki、Ishizuka Akane、Ito Yasuhiko、Koyama Takumi、Daigo Yataro、Takano Atsushi、Miyagi Yohei、Yokose Tomoyuki、Yamashita Toshinari、Sugahara Keisuke、Hino Okio、Yang Liying、Maruyama Reo、Katakura Akira、Yasukawa Takehiro、Orimo Akira
    • Journal Title

      Cancer Medicine

      Volume: 12 Issue: 17 Pages: 18062-18077

    • DOI

      10.1002/cam4.6421

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-22K17217, KAKENHI-PROJECT-23K14603, KAKENHI-PROJECT-21K07127, KAKENHI-PROJECT-22K20837, KAKENHI-PROJECT-22H04923, KAKENHI-PROJECT-23K27506
  • [Presentation] がん関連線維芽細胞CAFsで見出した転写因子LEF1の異常発現が引き起こすがん悪性化促進メカニズムの研究2023

    • Author(s)
      岡崎寛弥,施陽,咲本瑞来,小山侑,王子旭,石塚朱音,目澤義弘,梶野一徳,片倉朗,安川武宏,折茂彰
    • Organizer
      第82回日本学会学術集会
    • Data Source
      KAKENHI-PROJECT-22K20837
  • 1.  小山 侑
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi